PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27890927-7	2017	Importantly, knockdown of JUNB restored the response to dexamethasone in dexamethasone-resistant MM cells.	Dexamethasone	56-69	jun B proto-oncogene	Mus musculus	26-30	
27890927-7	2017	Importantly, knockdown of JUNB restored the response to dexamethasone in dexamethasone-resistant MM cells.	Dexamethasone	73-86	jun B proto-oncogene	Mus musculus	26-30	
27890927-8	2017	Moreover, 4-hydroxytamoxifen-induced activation of a JunB-ER fusion protein protected dexamethasone-sensitive MM cells against dexamethasone- and bortezomib-induced cytotoxicity.	Dexamethasone	86-99	jun B proto-oncogene	Mus musculus	53-57	
27890927-8	2017	Moreover, 4-hydroxytamoxifen-induced activation of a JunB-ER fusion protein protected dexamethasone-sensitive MM cells against dexamethasone- and bortezomib-induced cytotoxicity.	Dexamethasone	127-140	jun B proto-oncogene	Mus musculus	53-57	
1518304-4	1992	In contrast, DMSO-induced differentiation of F-MELC is associated with an early and transient induction of c-fos and junB mRNAs by 2 to 8 h treatment while in presence of dexamethasone, an inhibitor of F-MELC commitment, c-fos mRNA is not detected and junB mRNA remains at basal levels.	Dexamethasone	171-184	jun B proto-oncogene	Mus musculus	117-121	
1518304-4	1992	In contrast, DMSO-induced differentiation of F-MELC is associated with an early and transient induction of c-fos and junB mRNAs by 2 to 8 h treatment while in presence of dexamethasone, an inhibitor of F-MELC commitment, c-fos mRNA is not detected and junB mRNA remains at basal levels.	Dexamethasone	171-184	jun B proto-oncogene	Mus musculus	252-256